Schonfeld Strategic Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-44,265
Closed -$1.3M 2608
2025
Q4
$1.3M Sell
44,265
-79,442
-64% -$2.21M 0.01% 1015
2025
Q3
$3.12M Buy
123,707
+23,957
+24% +$584K 0.02% 813
2025
Q2
$2.39M Buy
+99,750
New +$2.31M 0.02% 890
2024
Q2
Sell
-9,200
Closed -$277K 2509
2024
Q1
$277K Buy
+9,200
New +$255K ﹤0.01% 1681

Other funds holding RTO

Schonfeld Strategic Advisors's RTO Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Rentokil (RTO) in Q1 2026, closing a stake of 44,265 shares — an estimated $1.3M sold.

Schonfeld Strategic Advisors first reported a position in RTO in Q1 2024 and held it in 4 quarters. The position peaked at $3.12M in Q3 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Rentokil position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 44,265 Rentokil shares in Q1 2026, an estimated $1.3M.
  • Schonfeld Strategic Advisors first reported a position in Rentokil in Q1 2024 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Rentokil position peaked at $3.12M in Q3 2025.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.